The development of paediatric medicines can be challenging since this is a different patient population with specific needs. A medicine designed for use in paed

Until the 1990s, it was generally accepted that medicines were first developed for adults and their use in children was investigated later, if at all. One of th

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used fo

Formulation is a key step in the drug design process, where the active drug is combined with other substances that maximise the therapeutic potential, safety an